Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05616819 · ClinicalTrials.gov registry record · NA
Effect of Morning Light Exposure on Mood
A NA study of Suicidal Ideation and Regulation, Emotion, sponsored by University of Arizona.
- Recruiting
- Registry status
- NA
- Development phase
- 480
- Enrollment target
- 1
- Study location
NCT05616819: Recruiting NA study of Suicidal Ideation and Regulation, Emotion, sponsored by University of Arizona.
NCT05616819 is a NA study of Suicidal Ideation and Regulation, Emotion that is actively recruiting participants, run by University of Arizona. The registered enrollment target is 480 participants, above the 262-participant average among 84 other Suicidal Ideation trials with a reported enrollment target (83% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05616819, a NA study of Suicidal Ideation and Regulation, Emotion, is actively recruiting participants, sponsored by University of Arizona.
- RECRUITING
- Registry status
- NA
- Development phase
- 480 participants
- Enrollment target
- 1
- Study location
Study Summary
Mood dysregulation and suicidal ideation are closely associated with disruption of sleep and circadian rhythms. Moreover, sleep problems and circadian disruption are commonplace features of military life. Critically, specifically timed light exposure plays a powerful role in regulating mood, circadian rhythms, and sleep-wake patterns. Therefore, investigators propose to conduct a large-scale clinical trial on the effectiveness of morning light exposure treatment for improving sleep-wake patterns, emotional and mental health, and suicidal thoughts in military personnel.
Primary Outcome
The mean response on the Beck Depression Inventory (BDI), which measures key symptoms of clinical depression. Higher scores on this measure indicate the presence of more severe depressive symptoms.
Conditions Studied
Interventions
- OTHER Active light exposure
- OTHER Placebo light exposure
Study Locations (1)
Arizona
- University of Arizona - Tucson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 480 participants |
| Start Date | 2023-07-01 |
| Est. Completion | 2026-01-01 |
| Phase | NA |
What NCT05616819 shows while recruiting
NCT05616819 is an interventional study that assigns participants to a tested intervention. The registered 480 participants enrollment target is mid-sized for trials with a published cap, above the 262-participant average among 84 other Suicidal Ideation trials with a reported enrollment target (83% higher).
The record links to 2 conditions, with Suicidal Ideation appearing as the primary indexed condition, and to 2 interventions - of which Active light exposure is the first listed.
NCT05616819 reports a single indexed study location in Arizona.
Frequently Asked Questions
What is clinical trial NCT05616819 about?
NCT05616819 is a clinical study titled "Effect of Morning Light Exposure on Mood". Mood dysregulation and suicidal ideation are closely associated with disruption of sleep and circadian rhythms. Moreover, sleep problems and circadian disruption are commonplace features of military life. Critically, specifically timed light exposure plays a powerful role in regulating mood, circadi...
What is the current status of trial NCT05616819?
This trial is currently recruiting. It is a NA study. The enrollment target is 480 participants. The study started on 2023-07-01. Estimated completion is 2026-01-01.
What conditions does trial NCT05616819 study?
This clinical trial studies the following conditions: Suicidal Ideation, Regulation, Emotion.
What interventions are being tested in trial NCT05616819?
The interventions under investigation include: Active light exposure (OTHER), Placebo light exposure (OTHER).
Who is sponsoring clinical trial NCT05616819?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05616819 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Suicidal Ideation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05616819's enrollment target sits among peer trials
480 11th of 84 higher than 74 of 84 other Suicidal Ideation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Suicidal Ideation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Randomized Clinical Trial of Supplementing Brief Psychotherapy With a Mobile App
RECRUITING · NA
-
Efficacy, Effectiveness, and Implementation of Jaspr Health in Emergency Department- Part A
RECRUITING · NA
-
Inhibitory Mechanisms of Negative Urgency in Adolescent Suicidal Behavior
RECRUITING · NA
-
Augmenting Massed Cognitive Processing Therapy (CPT) to Prevent Suicide Risk Among Patients With PTSD
RECRUITING · NA
-
Crisis Response Planning for Military Personnel
RECRUITING · NA
-
Suicide Intervention for Alaska Native Youth
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01954992 · 480 participants · Phase 3
Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer
- NCT03023696 · 480 participants · NA
Can Prophylactic Foraminotomy Prevent C5 Palsy
- NCT04948060 · 480 participants · NA
Tribally Engaged Approaches to Lung Screening (TEALS)
- NCT05053230 · 480 participants · NA
A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI